Dec. 08. 2022
Osaka, Japan – December 8, 2022 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) today announced the listing of six generic drugs with 12 strengths in the NHI (National Health Insurance) drug price list. Sawai’s product line now includes 335 compounds with 821 strengths.
The list of new products
1. Esomeprazole Capsules
| Generic name | Esomeprazole Magnesium Hydrate |
|---|---|
| Strengths | Tablets: 10mg, 20mg |
| Brand products | Nexium® Capsules 10mg, 20mg |
2. Escitalopram Tablets, OD Tablets
| Generic name | Escitalopram Oxalate |
|---|---|
| Strengths | Tablets: 10mg, 20mg OD Tablets: 10mg, 20mg |
| Brand products | Lexapro® Tablets 10mg, 20mg |
3. Ramelteon Tablets
| Generic name | Ramelteon |
|---|---|
| Strengths | 8mg |
| Brand products | Rozerem® Tablets 8mg |
4. Tolvaptan OD Tablets, Granules
| Generic name | Tolvaptan |
|---|---|
| Strengths | Granules: 1% OD Tablets: 7.5mg, 15mg |
| Brand products | Samsca® Granules 1% Samsca® OD Tablets 7.5mg, 15mg |
5. Ibandronate Intravenous Injection Syringes
| Generic name | Ibandronate Sodium Hydrate |
|---|---|
| Strengths | 1mg |
| Brand products | Bonviva® Syringes for Intravenous Injection 1mg |
6. Daptomycin for Intravenous Injection
| Generic name | Daptomycin |
|---|---|
| Strengths | 350mg |
| Brand products | Cubicin® IV 350mg |
The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.